1
Participants
Start Date
April 30, 2009
Primary Completion Date
March 31, 2011
Study Completion Date
March 31, 2011
Norditropin, Menostar 14mcg patch, Vivelle dot 25mcg patch
GH will be maintained at 0.05mg/kg/d, adjusted every 3 months. Estradiol 14mcg patch will be applied for 10 days/month for the first 6 months in Group 2. Estradiol 25mcg patch will be applied for 10 days/month for the second 6 months in Group 2, and for the first 6 months in Group 3. Estradiol 25mcg patch will be applied for 3 weeks per month for the second 6 months in Group 3.
John Hopkins University, Baltimore
University of Michigan, Ann Arbor
University of Chicago, Chicago
Collaborators (1)
Novo Nordisk A/S
INDUSTRY
University of Michigan
OTHER
Johns Hopkins University
OTHER
Massachusetts General Hospital
OTHER
University of Oklahoma
OTHER
University of South Florida
OTHER
Thomas Jefferson University
OTHER
University of Chicago
OTHER